103 related articles for article (PubMed ID: 8810610)
21. Increased expression of proinflammatory chemokines in bronchoalveolar lavage cells of patients with progressing idiopathic pulmonary fibrosis and sarcoidosis.
Ziegenhagen MW; Schrum S; Zissel G; Zipfel PF; Schlaak M; Müller-Quernheim J
J Investig Med; 1998 Jun; 46(5):223-31. PubMed ID: 9676055
[TBL] [Abstract][Full Text] [Related]
22. BAL in children: a controlled study of differential cytology and cytokine expression profiles by alveolar cells in pediatric sarcoidosis.
Tessier V; Chadelat K; Baculard A; Housset B; Clement A
Chest; 1996 Jun; 109(6):1430-8. PubMed ID: 8769489
[TBL] [Abstract][Full Text] [Related]
23. Spontaneous interleukin 2 release of bronchoalveolar lavage cells in sarcoidosis is a codeterminator of prognosis.
Müller-Quernheim J; Pfeifer S; Kienast K; Zissel G
Lung; 1996; 174(4):243-53. PubMed ID: 8791261
[TBL] [Abstract][Full Text] [Related]
24. [Spontaneous interleukin 1 secretion by alveolar macrophages from the bronchoalveolar lavage of patients with active sarcoidosis].
Barth J; Kreipe H; Radzun HJ; Schumacher U; Petermann W
Immun Infekt; 1989 Aug; 17(4):141-4. PubMed ID: 2789181
[TBL] [Abstract][Full Text] [Related]
25. Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis.
Robinson BW; McLemore TL; Crystal RG
J Clin Invest; 1985 May; 75(5):1488-95. PubMed ID: 3923038
[TBL] [Abstract][Full Text] [Related]
26. Spontaneous release of granulocyte colony-stimulating factor (G-CSF) by alveolar macrophages in the course of bacterial pneumonia and sarcoidosis: endotoxin-dependent and endotoxin-independent G-CSF release by cells recovered by bronchoalveolar lavage.
Tazi A; Nioche S; Chastre J; Smiéjan JM; Hance AJ
Am J Respir Cell Mol Biol; 1991 Feb; 4(2):140-7. PubMed ID: 1703767
[TBL] [Abstract][Full Text] [Related]
27. Increased expression of IL-12 receptor mRNA in active pulmonary tuberculosis and sarcoidosis.
Taha RA; Minshall EM; Olivenstein R; Ihaku D; Wallaert B; Tsicopoulos A; Tonnel AB; Damia R; Menzies D; Hamid QA
Am J Respir Crit Care Med; 1999 Oct; 160(4):1119-23. PubMed ID: 10508796
[TBL] [Abstract][Full Text] [Related]
28. Alveolar macrophages from patients with beryllium disease and sarcoidosis express increased levels of mRNA for tumor necrosis factor-alpha and interleukin-6 but not interleukin-1 beta.
Bost TW; Riches DW; Schumacher B; Carré PC; Khan TZ; Martinez JA; Newman LS
Am J Respir Cell Mol Biol; 1994 May; 10(5):506-13. PubMed ID: 8179912
[TBL] [Abstract][Full Text] [Related]
29. In vitro release of interleukin-15 by broncho-alveolar lavage cells and peripheral blood mononuclear cells from patients with different lung diseases.
Zissel G; Bäumer I; Schlaak M; Müller-Quernheim J
Eur Cytokine Netw; 2000 Mar; 11(1):105-12. PubMed ID: 10705307
[TBL] [Abstract][Full Text] [Related]
30. Mechanisms of fibrosis in coal workers' pneumoconiosis. Increased production of platelet-derived growth factor, insulin-like growth factor type I, and transforming growth factor beta and relationship to disease severity.
Vanhee D; Gosset P; Wallaert B; Voisin C; Tonnel AB
Am J Respir Crit Care Med; 1994 Oct; 150(4):1049-55. PubMed ID: 7921435
[TBL] [Abstract][Full Text] [Related]
31. Mast cells and pulmonary fibrosis. Identification of a histamine releasing factor in bronchoalveolar lavage fluid.
Broide DH; Smith CM; Wasserman SI
J Immunol; 1990 Sep; 145(6):1838-44. PubMed ID: 1697311
[TBL] [Abstract][Full Text] [Related]
32. Highly activated T-cell receptor AV2S3(+) CD4(+) lung T-cell expansions in pulmonary sarcoidosis.
Katchar K; Wahlström J; Eklund A; Grunewald J
Am J Respir Crit Care Med; 2001 Jun; 163(7):1540-5. PubMed ID: 11401870
[TBL] [Abstract][Full Text] [Related]
33. Expression and role of CCR6/CCL20 chemokine axis in pulmonary sarcoidosis.
Facco M; Baesso I; Miorin M; Bortoli M; Cabrelle A; Boscaro E; Gurrieri C; Trentin L; Zambello R; Calabrese F; Cassatella MA; Semenzato G; Agostini C
J Leukoc Biol; 2007 Oct; 82(4):946-55. PubMed ID: 17615381
[TBL] [Abstract][Full Text] [Related]
34. Anti-endothelial cell antibodies in patients with sarcoidosis.
Inui N; Matsui T; Suda T; Chida K
Chest; 2008 Apr; 133(4):955-60. PubMed ID: 18398116
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of inflammatory cytokine secretion by human alveolar macrophages.
Losa García JE; Rodríguez FM; Martín de Cabo MR; García Salgado MJ; Losada JP; Villarón LG; López AJ; Arellano JL
Mediators Inflamm; 1999; 8(1):43-51. PubMed ID: 10704089
[TBL] [Abstract][Full Text] [Related]
36. Activated T cells and cytokines in bronchoalveolar lavages from patients with various lung diseases associated with eosinophilia.
Walker C; Bauer W; Braun RK; Menz G; Braun P; Schwarz F; Hansel TT; Villiger B
Am J Respir Crit Care Med; 1994 Oct; 150(4):1038-48. PubMed ID: 7921434
[TBL] [Abstract][Full Text] [Related]
37. The effect of an oral anti-oxidant, N-Acetyl-cysteine, on inflammatory and oxidative markers in pulmonary sarcoidosis.
Hamzeh N; Li L; Barkes B; Huang J; Canono B; Gillespie M; Maier L; Day B
Respir Med; 2016 Mar; 112():106-11. PubMed ID: 26831541
[TBL] [Abstract][Full Text] [Related]
38. Increased release of transforming growth factor (TGF)-beta1, TGF-beta2, and chemoattractant mediators in pneumonia.
Bühling F; Thölert G; Kaiser D; Hoffmann B; Reinhold D; Ansorge S; Welte T
J Interferon Cytokine Res; 1999 Mar; 19(3):271-8. PubMed ID: 10213466
[TBL] [Abstract][Full Text] [Related]
39. Spontaneous hydrogen peroxide release from alveolar macrophages of patients with active sarcoidosis: comparison with cigarette smokers.
Baughman RP; Lower EE; Pierson G; Strohofer S
J Lab Clin Med; 1988 Apr; 111(4):399-404. PubMed ID: 3127508
[TBL] [Abstract][Full Text] [Related]
40. Ultrastructural types of alveolar macrophages in bronchoalveolar lavages from patients with pulmonary sarcoidosis.
Burkhardt O; Lode H; Welte T; Merker HJ
Micron; 2007; 38(6):572-9. PubMed ID: 17127071
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
